Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study.
Gagliardini R, Baccini M, Modica S, Montagnani F, Zanelli G, Borghetti A, Dreassi E, Lombardi F, Pecorari M, Borghi V, Callegaro A, Micheli V, Lodi MA, Rossetti B, Zazzi M; ARCA cohort.
Gagliardini R, et al. Among authors: dreassi e.
J Glob Antimicrob Resist. 2022 Mar;28:274-281. doi: 10.1016/j.jgar.2022.01.018. Epub 2022 Jan 26.
J Glob Antimicrob Resist. 2022.
PMID: 35092828
Free article.